Experimental and Therapeutic Medicine · 2019 · 14 citations · 23 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologySignal TransductionCancer Cell SignalingCancer ProgressionEpithelial-mesenchymal TransitionLung CancerLung MetastasisMalignant NeoplasmsCancer Signaling PathwaysCell Migration AnalysisDisease-free Survival AnalysisDisease-free Survival AssessmentEpithelial-mesenchymal Transition In CancerInvasion-metastasis CascadeKaplan-meier Confidence IntervalsTumor-node-metastasis Staging
Non-small cell lung cancer (NSCLC) is one of the most common cancer types worldwide. Previous studies have indicated that TOR signaling pathway regulator (TIPRL) is involved in the progression of NSCLC. However, the underlying mechanisms of the role of TIPRL in regulating NSCLC metastasis have remained largely elusive. In the present study, the expression pattern of TIPRL in NSCLC was analyzed using The Cancer Genome Atlas (TCGA) dataset. Furthermore, Kaplan-Meier curve analysis was performed to evaluate the prognostic value of TIPRL in NSCLC, using the Kaplan-Meier Plotter and TCGA datasets. Loss-of-function assays were performed to determine the effects of TIPRL on cell migration and invasion. The results suggested that TIPRL was upregulated in NSCLC and positively associated with an advanced Tumor-Node-Metastasis stage. A higher expression level of TIPRL was associated with shorter overall and disease-free survival times in patients with NSCLC. To the best of our knowledge, the present study was the first to report that TIPRL acts as a metastasis promoter in NSCLC. Silencing of TIPRL suppressed A549 cell migration and invasion. Mechanistically, the present study indicated that TIPRL knockdown significantly promoted epithelial-cadherin expression, whereas it suppressed twist and vimentin expression in A549 cells. In conclusion, the present analysis suggested that TIPRL may serve as a biomarker for the prognosis of NSCLC and as a future target for its treatment.
23
LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji, Matthew R. Ramsey, D. Neil Hayes et al. · Nature · 2007 · 1.1K citations
Medicine, Cancer Biology, Oncology +11
WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
Don X. Nguyen, Anne C. Chiang, Xiang H.-F. Zhang et al. · Cell · 2009 · 629 citations · Full text
Medicine, Cancer Biology, Oncology +14
Non–small-cell Lung Cancer With Brain Metastasis at Presentation
Saiama N. Waqar, Pamela Samson, Clifford G. Robinson et al. · Clinical Lung Cancer · 2018 · 253 citations · Full text